In a study of 120 breast cancer patients, DOX, PTX, and TZ treatments significantly increased hsCRP, TNF-a, and triglyceride levels, indicating cardiotoxicity. Regular monitoring of markers like CK-MB and hsCRP, along with adherence to CV guidelines, is essential for early intervention. Here, TNF is linked to breast cancer.